Atara Biotherapeutics Inc (NASDAQ:ATRA)

17.61
Delayed Data
As of Nov 26
 -0.58 / -3.20%
Today’s Change
11.81
Today|||52-Week Range
28.20
-10.29%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Atara Biotherapeutics Inc have a median target of 27.50, with a high estimate of 78.00 and a low estimate of 10.00. The median estimate represents a +56.16% increase from the last price of 17.61.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Atara Biotherapeutics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.75
Sales
$27.2M
Reporting Date
Mar 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 16.61%
 
 
 
 
 
 
Growthannually 17.02%
 
 
 
 
 
 

Sales

Growthquarterly 407.16%
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.